Moderna Executive and Leadership Team

Stéphane Bancel, the Chief Executive Officer at Moderna, directs the company's overarching strategy and vision, guiding its pioneering work in mRNA medicine. Bancel oversees the integration of scientific innovation with advanced technology to transform disease prevention and treatment. This leadership involves driving the development of mRNA-based therapies across infectious diseases, cancer, rare disorders, and autoimmune conditions. Under Bancel's direction, Moderna focuses on creating medicines with a meaningful and lasting impact on human health globally. The Chief Executive Officer ensures alignment across all departments, fostering a culture dedicated to improving lives through groundbreaking science. Stéphane Bancel's strategic oversight is critical to Moderna's mission of making mRNA a new class of medicines.

Jamey Mock, the Chief Financial Officer at Moderna, manages the company's financial strategy and operations, ensuring robust fiscal health to support groundbreaking mRNA research and development. Mock oversees all financial planning, accounting, and reporting functions, providing critical insights that enable strategic decision-making across infectious diseases, cancer, rare disorders, and autoimmune challenges. This leadership position is vital for securing investment, managing capital allocation, and driving financial efficiency to accelerate the delivery of transformative medicines. The Chief Financial Officer ensures that Moderna's financial framework aligns with its mission to improve global human health. Jamey Mock's financial stewardship is essential for sustaining Moderna's pioneering efforts in mRNA technology.

Amy Mahery, the Chief Marketing Officer at Moderna, spearheads the strategic positioning and market communication for the company's innovative mRNA therapies. Mahery directs initiatives to articulate the transformative potential of mRNA medicine across infectious diseases, oncology, rare disorders, and autoimmune conditions. This role involves translating complex scientific advancements into clear value propositions for diverse stakeholders, including healthcare providers, patients, and partners. The Chief Marketing Officer ensures that Moderna's commitment to improving human health is effectively communicated, driving awareness and adoption of its groundbreaking treatments. Amy Mahery's leadership shapes the narrative around mRNA's impact, reinforcing Moderna's position as a pioneer in the field.

Michael Aihe, the Manager, Chief Marketing Officer Planning, Supply Chain at Moderna, optimizes the planning and execution of supply chain operations critical to delivering mRNA medicines. Aihe focuses on ensuring the efficient and reliable flow of materials and products, supporting the company's mission to prevent and treat diseases across various therapeutic areas. This role involves close collaboration with marketing and operational teams to align supply chain capabilities with market demands and strategic objectives. The Manager, Chief Marketing Officer Planning, Supply Chain ensures that Moderna's innovative treatments reach patients effectively and on time. Michael Aihe's contributions are integral to maintaining the integrity and responsiveness of Moderna's global supply network.

Michelle Patel, the Chief of Staff, Oncology at Moderna, drives strategic initiatives and operational excellence within the company's oncology division. Patel supports the advancement of mRNA-based cancer therapies, ensuring alignment with Moderna's broader mission to transform disease treatment. This role involves coordinating cross-functional efforts, managing key projects, and facilitating communication between leadership and the oncology research teams. The Chief of Staff, Oncology plays a crucial part in accelerating the development and delivery of innovative cancer medicines. Michelle Patel's focus is on enhancing the efficiency and impact of Moderna's oncology pipeline, contributing significantly to the fight against cancer.

Jeffrey Salling, the Chief of Staff & Operations Senior Director, Legal at Moderna, enhances the operational efficiency and strategic execution of the company's legal department. Salling oversees critical operational functions, ensuring the legal team effectively supports Moderna's pioneering work in mRNA medicine development and commercialization. This position involves streamlining processes, managing resources, and facilitating seamless collaboration across legal and business units. The Chief of Staff & Operations Senior Director, Legal ensures that legal operations are robust and aligned with Moderna's mission to improve human health. Jeffrey Salling's expertise is vital for maintaining strong governance and supporting the company's rapid growth and innovation.

Paula Rodríguez, the Senior Chief Marketing Officer, Operations & Specialist at Moderna, leads specialized marketing efforts focused on operational aspects and specific market segments. Rodríguez directs strategies that enhance the understanding and reach of Moderna's mRNA therapies, particularly concerning their operational deployment and specialized applications. This role involves deep analysis of market dynamics and operational requirements to ensure effective communication and market penetration. The Senior Chief Marketing Officer, Operations & Specialist collaborates closely with product development and supply chain teams to translate operational strengths into market advantages. Paula Rodríguez's expertise is key to refining Moderna's market presence and supporting its mission to improve global health outcomes.

Sameh Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, drives market intelligence and strategic marketing initiatives for the company's innovative mRNA platform. Ismail conducts in-depth analysis to inform marketing strategies, ensuring that Moderna's advancements in infectious diseases, cancer, rare disorders, and autoimmune conditions are effectively communicated to target audiences. This dual role combines analytical rigor with strategic marketing leadership, focusing on identifying market opportunities and optimizing campaign performance. The Chief Marketing Officer & Senior Analyst plays a critical part in shaping Moderna's market perception and supporting its mission to improve human health. Sameh Ismail's analytical insights are crucial for guiding marketing efforts and demonstrating the value of mRNA medicine.

Sam Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, contributes analytical expertise to the company's marketing strategies, focusing on data-driven insights for its mRNA therapies. Ismail analyzes market trends and performance metrics to refine communication approaches for infectious diseases, oncology, rare disorders, and autoimmune conditions. This role supports the effective dissemination of information regarding Moderna's scientific breakthroughs and their potential impact on global health. The Chief Marketing Officer & Senior Analyst ensures that marketing efforts are precisely targeted and demonstrably effective. Sam Ismail's analytical contributions are vital for optimizing Moderna's market engagement and reinforcing its leadership in mRNA medicine.

Richard Mason, the Senior Specialist, External Manufacturing - Chief Marketing Officer Operations at Moderna, oversees critical aspects of external manufacturing operations that support marketing and product delivery. Mason ensures that third-party manufacturing partners adhere to stringent quality standards and production timelines, vital for the consistent supply of mRNA medicines. This role involves close coordination with both the marketing and manufacturing teams to align production capabilities with market demand and strategic objectives. The Senior Specialist, External Manufacturing - Chief Marketing Officer Operations plays a key part in maintaining the integrity of Moderna's supply chain. Richard Mason's focus on operational excellence in external manufacturing is essential for delivering on Moderna's promise to improve human health.